Reconnect Labs is a Swiss, clinical stage biopharmaceutical company on a mission to disrupt the cycle of illness that underlies mental health conditions.
Leveraging decades of expertise and a world-class network of leaders in clinical drug development, Reconnect Labs is progressing the development of rapid-acting precision psychiatry designed drug candidates with the potential to transform the treatment landscape for insomnia and psychiatric conditions such as PTSD and substance use disorders.
With our innovative approach to the design of precision therapeutics, and use of digital psychiatry tools as precision diagnostics, we aim to deliver commercially scalable and accessible treatments that will provide both immediate symptom alleviation and durable, long-term, disease modifying therapeutic benefits.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Lenggstrasse 31, Zurich,zurich 8008,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- reconnect-foundation.org
- Keywords
- CNS & Psychiatry, Drug Development, Precision Psychiatry, Sleep Pharmacology, Interventional Psychiatry, Psychedelic Therapeutics, Psychedelic Research, Precision Therapeutics.
- HQ
- Zurich, Zurich
- Competitors
- Journey Clinical, Negev Capital, Solvonis Therapeutics (formerly Awakn), PALA - Psychedelics Association of Lausanne for Awareness, Lionheart Ventures, Galventa AG, ALPS Foundation - Awareness Lectures on Psychedelics in Switzerland, Johns Hopkins Center for Psychedelic and Consciousness Research, atai Life Sciences, Lykos Therapeutics.
Reconnect Labs Questions
Reconnect Labs's website is reconnect-foundation.org
Reconnect Labs's LinkedIn profile is https://ch.linkedin.com/company/reconnect-labs
Reconnect Labs has
8 employees.
View email and phone details for 8
employees at Reconnect Labs.
Reconnect Labs's industry is
Biotechnology Research
Reconnect Labs's top competitors are
Journey Clinical,
Negev Capital,
Solvonis Therapeutics (Formerly Awakn),
Pala - Psychedelics Association Of Lausanne For Awareness,
Lionheart Ventures,
Galventa Ag,
Alps Foundation - Awareness Lectures On Psychedelics In Switzerland,
Johns Hopkins Center For Psychedelic And Consciousness Research,
Atai Life Sciences,
Lykos Therapeutics.
Reconnect Labs's categories are Biotechnology Research
Reconnect Labs's founding year is 2021
